LATOXAP

国: イスラエル

言語: 英語

ソース: Ministry of Health

有効成分:

LATANOPROST; TIMOLOL AS MALEATE

から入手可能:

PERRIGO ISRAEL AGENCIES LTD

ATCコード:

S01ED01

医薬品形態:

EYE DROPS

構図:

TIMOLOL AS MALEATE 5 MG / 1 ML; LATANOPROST 0.05 MG / 1 ML

投与経路:

OCULAR

処方タイプ:

Required

製:

AEROPHARM GMBH, GERMANY

治療領域:

TIMOLOL

適応症:

Reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.

承認日:

2015-09-20

情報リーフレット

PATIENT PACKAGE INSERT IN
ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed with
a doctor’s prescription only
LATOXAP
EYE DROPS
Latanoprost 0.05 mg/ml
Timolol (as Maleate) 5 mg/ml
For the list of inactive and allergenic ingredients in the
preparation, please see section 6.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING
THE MEDICINE. This leaflet contains concise information
about the medicine. If you have further questions, refer
to the doctor or pharmacist.
This medicine has been prescribed to treat you. Do not
pass it on to others. It may harm them even if it seems
to you that their medical condition is similar to yours.
THIS MEDICINE IS INTENDED FOR TREATMENT OF ADULTS OVER
18 YEARS OF AGE.
The preparation contains benzalkonium chloride (a
preservative) that may cause irritation in the eyes and
may be absorbed by contact lenses and lead to their
discoloration. Avoid contact between the medicine
and soft contact lenses. See section 3: "How should
you use the medicine?".
1.
WHAT IS THE MEDICINE INTENDED FOR?
To reduce intraocular pressure in patients suffering from
open-angle glaucoma and from increased intraocular
pressure that are not fully responsive to beta blockers.
THERAPEUTIC GROUP:
Latanoprost - prostaglandin F2 analogue
Timolol – beta blocker
2.
BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
∙ you are sensitive (allergic) to the active ingredients
or to any of the other ingredients contained in this
medicine (see section 6).
∙ you are sensitive (allergic) to preparations from the
beta blockers group
∙ you are suffering, or have suffered in the past,
from disturbances in the respiratory system, such
as: asthma, severe chronic obstructive bronchitis
(a severe lung disease that can be manifested
by breathing difficulty, heavy breathing and/or
prolonged cough)
∙ you are suffering from severely impaired heart
function or from severe heart rate disturbances
∙ you are pregnant, plan to become pregnant or are
breastfeeding
DO NOT USE